Global pharmaceutical and biotechnology giant Pfizer (PFE) revealed that it has commenced patient dosing in its phase 3 clinical trial, TALAPRO-3, which will …
BioNTech SE (BNTX) and its partner Pfizer (PFE) have received Conditional Marketing Authorization (CMA) in the E.U.
GlaxoSmithKline (GSK) and Vir Biotechnology’s (VIR) investigational single-dose monoclonal antibody sotrovimab (previously named VIR-7831) has been authorized for emergency use by the U.S.
Pfizer Inc. (PFE) and Myovant Sciences (MYOV) announced that they have received the U.
Pfizer Inc and BioNTech SE have inked an agreement to supply 200 million additional doses of their COVID-19 vaccine to 27 European Union …
Israel’s largest health maintenance organization (HMO), Clalit Health Services Research Institute, has published a research paper that confirms the efficacy of Pfizer’s COVID-19 …
Sanofi’s CEO, Paul Hudson, said that the mRNA-based (messenger Ribonucleic acid) COVID-19 vaccine developed by the pharma giant and Translate Bio will not …
Pfizer-BioNTech’s COVID-19 vaccine has been cleared by Australia’s health regulator to be used for immunization in individuals aged 16 years and older. This …
Pfizer and BioNTech’s coronavirus vaccine may be effective in neutralizing rapidly spreading variants of SARS-CoV2 that have developed in the UK and South …
With COVID-19 cases continuing to surge, the attention of the whole world is currently on pharma companies developing potential treatments and vaccines for …
